RecallDepth
Class III Terminated

Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.

This recall has been terminated (originally issued August 3, 2016).

Company
Teva North America
Recall Initiated
May 18, 2016
Posted
August 3, 2016
Recall Number
D-1449-2016
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
14, 370 units
Firm Location
Horsham, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Tablet/Capsule Specifications

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: 02D163, Exp. 9/2017

More recalls by Teva North America

View all recalls by this company →

Other recent Class III Drug recalls